Series A - Satellite Bio
Investment Firm
Overview
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.
Announced Date
Mar 07, 2022
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
Polaris Partners
Polaris Partners is a early_stage_venture and late_stage_venture and private_equity and seed and venture firm.
aMoon Fund
aMoon Fund is a debt and early_stage_venture and late_stage_venture and post_ipo and venture firm.
Lightspeed Venture Partners
Lightspeed Venture Partners is a early_stage_venture and late_stage_venture and seed firm.
Participant Investors
6
Round Details and Background
Satellite Bio raised $82470989 on 2022-03-07 in Series A
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 07, 2022 |  Series A - Satellite Bio | 7 | - | 82.5M |
| Nov 17, 2020 | Seed Round - Satellite Bio | 3 | - | 19.0M |
Recent Activity
There is no recent news or activity for this profile.